Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-20-000988

Options or other derivatives

  • President and CEO acquired 190,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

KIDRON NADAV · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-01-08 Grant or award : show line 1 in the form Stock Option (right to buy) +190,000 190,000 D
Loading xslF345X03/ownership.xml…